Live Breaking News & Updates on Curie Therapeutics

Stay updated with breaking news from Curie therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cancer Biotech Abdera Reveals $142M for Better Antibody-Based Radiation Drugs

Abdera Therapeutics emerged from stealth with technology that improves the way antibodies deliver radiopharmaceuticals for cancer. A lead program with preclinical proof-of-concept data in small cell lung cancer is on track to reach the clinic in 2024. ....

United Kingdom , United States , British Columbia , Menlo Park , Joel Drewry , Abcellera Biologics , Lana Janes , Mike Abrams , Lori Lyons Williams , Novartis Lutathera , Bristol Myers Squibb , Genevant Sciences , Tekmira Pharmaceuticals , Abdera Therapeutics , Madam Judge , Mare Bioinnovations , Versant Ventures , Northview Ventures , Bio Partners , Viking Global Investors , Qiming Venture Partners United States , Abdera President , Noria Therapeutics , Aktis Oncology , Mariana Oncology , Curie Therapeutics ,

NorthStar Medical Radioisotopes Provides Updates on Corporate Progress and Upcoming Milestones

NorthStar’s Mo-99 program continues at the forefront of U.S. radioisotope production as the only commercialized producer of key medical radioisotopes molybdenum-99 (Mo-99)/technetium-99m (Tc-99m ....

United States , University Of Missouri , Eckert Ziegler , Radiopharm Theranostics , Frank Scholz , Stephen Merrick , Northstar Beloit , Clarity Pharmaceuticals , Radiopharmaceutical Contract Development , Manufacturing Organization , Corporate Development , Ge Healthcare , He High Energy , Northstar Medical Radioisotopes , Regulatory Affairs , Company Beloit , Drug Administration , Engineering Technology , Organizational Health , University Of Missouri Research Reactor , Company Human Resources , Program Management , Chief Executive Officer , Northstar Medical , Radiogenix Systems , Capella Imaging ,

BioSpace Names Most Promising New Biopharma Companies to Watch in 2023

/PRNewswire/ BioSpace, the leading life sciences news and careers site, has announced its 2023 selections for the industry s most promising up-and-coming. ....

United States , Josh Goodwin , Prnewswire Biospace , Umoja Biopharma , Nextgen Bio , Seismic Therapeutic Inc , Idrx Inc , Chroma Medicine Inc , Septerna Inc , Triana Biomedicines Inc , Neumora Therapeutics , Altos Labs , Odyssey Therapeutics , Affinit Therapeutics , Upstream Bio , Eikon Therapeutics , Prime Medicine , Gen Bio , Capstan Therapeutics , Alto Neuroscience , Intergalactic Therapeutics , Chroma Medicine , Ceptur Therapeutics , Clade Therapeutics , Satellite Bio , Ambagon Therapeutics ,

NorthStar Medical Radioisotopes and Curie Therapeutics Announce Priority Access Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)

Curie Therapeutics will be provided with priority access to NorthStar’s high purity non-carrier added (n.c.a.) Ac-225, which will be used to advance its multimodal pipeline of precision radiopharmaceuticals to address broad unmet needs in treatment of patients with solid tumors ....

Stephen Merrick , Curie Therapeutics Inc , Northstar Medical Radioisotopes , Curie Therapeutics , Chief Executive Officer , Northstar Medical , Drug Master File , Simon Read , Chief Executive ,

Oncoinvent to Present at Guggenheim Radiopharmaceuticals Day

Oncoinvent AS, a clinical stage company advancing a pipeline of radiopharmaceutical products across a variety of solid cancers, today announced that members of management will present at the Guggenheim ....

New York , United States , Jana Alfheim , Courtney Turiano , Kostenloser Wertpapierhandel , Charles Zhu , Fusion Pharmaceuticals , Linear Energy Transfer , Guggenheim Securities , Guggenheim Radiopharmaceuticals Day , Point Biopharma , Aktis Oncology , Curie Therapeutics , Vice President Guggenheim Securities , Chief Executive Officer , Stern Investor Relations ,